Logo image of CVV.CA

CANALASKA URANIUM LTD (CVV.CA) Stock Fundamental Analysis

Canada - TSX-V:CVV - CA13709C1005 - Common Stock

0.89 CAD
-0.01 (-1.11%)
Last: 10/27/2025, 7:00:00 PM
Fundamental Rating

2

CVV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. While CVV seems to be doing ok healthwise, there are quite some concerns on its profitability. CVV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

CVV had negative earnings in the past year.
In the past year CVV has reported a negative cash flow from operations.
In the past 5 years CVV always reported negative net income.
In the past 5 years CVV always reported negative operating cash flow.
CVV.CA Yearly Net Income VS EBIT VS OCF VS FCFCVV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

1.2 Ratios

CVV's Return On Assets of -61.04% is on the low side compared to the rest of the industry. CVV is outperformed by 82.86% of its industry peers.
CVV has a Return On Equity of -71.04%. This is in the lower half of the industry: CVV underperforms 75.24% of its industry peers.
Industry RankSector Rank
ROA -61.04%
ROE -71.04%
ROIC N/A
ROA(3y)-52.11%
ROA(5y)-47.93%
ROE(3y)-61.88%
ROE(5y)-55.3%
ROIC(3y)N/A
ROIC(5y)N/A
CVV.CA Yearly ROA, ROE, ROICCVV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

CVV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CVV.CA Yearly Profit, Operating, Gross MarginsCVV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

6

2. Health

2.1 Basic Checks

CVV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CVV has more shares outstanding
Compared to 1 year ago, CVV has an improved debt to assets ratio.
CVV.CA Yearly Shares OutstandingCVV.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CVV.CA Yearly Total Debt VS Total AssetsCVV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

CVV has an Altman-Z score of 24.45. This indicates that CVV is financially healthy and has little risk of bankruptcy at the moment.
CVV has a better Altman-Z score (24.45) than 93.33% of its industry peers.
CVV has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.03, CVV is doing good in the industry, outperforming 75.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 24.45
ROIC/WACCN/A
WACCN/A
CVV.CA Yearly LT Debt VS Equity VS FCFCVV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 8.11 indicates that CVV has no problem at all paying its short term obligations.
CVV has a better Current ratio (8.11) than 93.81% of its industry peers.
A Quick Ratio of 8.11 indicates that CVV has no problem at all paying its short term obligations.
CVV has a better Quick ratio (8.11) than 94.29% of its industry peers.
Industry RankSector Rank
Current Ratio 8.11
Quick Ratio 8.11
CVV.CA Yearly Current Assets VS Current LiabilitesCVV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

0

3. Growth

3.1 Past

The earnings per share for CVV have decreased strongly by -18.66% in the last year.
EPS 1Y (TTM)-18.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -15.47% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-33.33%
EPS Next 2Y-15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVV.CA Yearly EPS VS EstimatesCVV.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.02 -0.04 -0.06 -0.08

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVV.CA Price Earnings VS Forward Price EarningsCVV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVV.CA Per share dataCVV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

CVV's earnings are expected to decrease with -15.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CVV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANALASKA URANIUM LTD

TSX-V:CVV (10/27/2025, 7:00:00 PM)

0.89

-0.01 (-1.11%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)09-25 2025-09-25/amc
Earnings (Next)12-15 2025-12-15
Inst Owners32.21%
Inst Owner ChangeN/A
Ins Owners3.61%
Ins Owner ChangeN/A
Market Cap170.36M
Revenue(TTM)N/A
Net Income(TTM)-13603000
Analysts83.64
Price Target1.61 (80.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.36%
Min EPS beat(2)-45.63%
Max EPS beat(2)2.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.9
P/tB 8.9
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.04%
ROE -71.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.11%
ROA(5y)-47.93%
ROE(3y)-61.88%
ROE(5y)-55.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.11
Quick Ratio 8.11
Altman-Z 24.45
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)125.08%
Cap/Depr(5y)290.51%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.55%
EPS Next Y-33.33%
EPS Next 2Y-15.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-19.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.49%
OCF growth 3YN/A
OCF growth 5YN/A

CANALASKA URANIUM LTD / CVV.CA FAQ

Can you provide the ChartMill fundamental rating for CANALASKA URANIUM LTD?

ChartMill assigns a fundamental rating of 2 / 10 to CVV.CA.


What is the valuation status for CVV stock?

ChartMill assigns a valuation rating of 0 / 10 to CANALASKA URANIUM LTD (CVV.CA). This can be considered as Overvalued.


How profitable is CANALASKA URANIUM LTD (CVV.CA) stock?

CANALASKA URANIUM LTD (CVV.CA) has a profitability rating of 0 / 10.


What is the expected EPS growth for CANALASKA URANIUM LTD (CVV.CA) stock?

The Earnings per Share (EPS) of CANALASKA URANIUM LTD (CVV.CA) is expected to decline by -33.33% in the next year.